Trump's chloroquine push came after talk with one of his top supporters in the tech industry, Oracle Chairman Larry Ellison, source says.
nbcnews.com/politics/donal… via @nbcnews
nbcnews.com/politics/donal… via @nbcnews
The administration was pushing for a nationwide expanded access program that would provide chloroquine with limited physician oversight, the source said.
“Dr. Bright and his team were insisting upon a randomized controlled clinical study because there was insufficient
“Dr. Bright and his team were insisting upon a randomized controlled clinical study because there was insufficient
information on the benefit and the potential harms of the drug to patients with COVID-19," the source said. Implementing an Emergency Use Authorization to send the medication to the National Stockpile, the source said, was a compromise between the two positions.
